Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management

NCT06627595 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT06627595
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06627595 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Physical Activity on Immunotherapy-induced Toxicities in Melanoma Management
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Recruiting
Start date
November 5, 2024
Completion date
May 5, 2028
Enrollment
160 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

immunotoxicity, melanoma